CRC
Clinical trials for CRC explained in plain language.
Never miss a new study
Get alerted when new CRC trials appear
Sign up with your email to follow new studies for CRC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat colorectal cancer: targeted combo shows promise
Disease control OngoingThis study tests a new drug called onvansertib added to standard chemotherapy for people with advanced colorectal cancer that has certain gene mutations (KRAS or NRAS). About 113 participants will receive either the standard treatment or the standard plus onvansertib. The goal is…
Matched conditions: CRC
Phase: PHASE2 • Sponsor: Cardiff Oncology • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
Cancer combo trial pulled before it even started
Disease control TerminatedThis study was designed to test a new drug, NGM707, combined with the immunotherapy pembrolizumab in people with advanced or metastatic solid tumors that could not be removed by surgery. The goal was to see if the combination could shrink tumors and to monitor side effects. Howev…
Matched conditions: CRC
Phase: PHASE2 • Sponsor: NGM Biopharmaceuticals, Inc • Aim: Disease control
Last updated May 20, 2026 11:53 UTC